Senseonics (SENS) Competitors $0.48 +0.01 (+1.86%) Closing price 04:00 PM EasternExtended Trading$0.48 0.00 (-0.66%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SENS vs. TRNS, EYPT, ALNT, AEHR, LAB, CTKB, QTRX, FEIM, QSI, and MASSShould you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include Transcat (TRNS), EYEPOINT PHARMACEUTICALS (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Standard BioTools (LAB), Cytek Biosciences (CTKB), Quanterix (QTRX), Frequency Electronics (FEIM), Quantum-Si (QSI), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Senseonics vs. Its Competitors Transcat EYEPOINT PHARMACEUTICALS Allient Aehr Test Systems Standard BioTools Cytek Biosciences Quanterix Frequency Electronics Quantum-Si 908 Devices Transcat (NASDAQ:TRNS) and Senseonics (NYSE:SENS) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability. Do insiders and institutionals believe in TRNS or SENS? 98.3% of Transcat shares are held by institutional investors. Comparatively, 12.4% of Senseonics shares are held by institutional investors. 2.8% of Transcat shares are held by company insiders. Comparatively, 4.3% of Senseonics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, TRNS or SENS? Transcat has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Is TRNS or SENS more profitable? Transcat has a net margin of 4.64% compared to Senseonics' net margin of -362.30%. Transcat's return on equity of 6.66% beat Senseonics' return on equity.Company Net Margins Return on Equity Return on Assets Transcat4.64% 6.66% 5.09% Senseonics -362.30%-842.25%-67.99% Which has better valuation and earnings, TRNS or SENS? Transcat has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranscat$278.42M2.87$14.52M$1.4360.04Senseonics$25.47M12.39-$60.39M-$0.10-4.82 Does the media prefer TRNS or SENS? In the previous week, Transcat had 2 more articles in the media than Senseonics. MarketBeat recorded 8 mentions for Transcat and 6 mentions for Senseonics. Transcat's average media sentiment score of 1.20 beat Senseonics' score of 0.04 indicating that Transcat is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Senseonics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer TRNS or SENS? Transcat currently has a consensus target price of $112.20, indicating a potential upside of 30.68%. Senseonics has a consensus target price of $1.55, indicating a potential upside of 221.44%. Given Senseonics' stronger consensus rating and higher possible upside, analysts plainly believe Senseonics is more favorable than Transcat.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Transcat 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Senseonics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 SummaryTranscat beats Senseonics on 11 of the 17 factors compared between the two stocks. Get Senseonics News Delivered to You Automatically Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SENS vs. The Competition Export to ExcelMetricSenseonicsProcess control instruments IndustryMedical SectorNYSE ExchangeMarket Cap$315.46M$18.85B$5.64B$20.98BDividend YieldN/A0.61%4.64%3.65%P/E Ratio-3.7118.2230.1128.93Price / Sales12.396.64452.2459.74Price / CashN/A22.2637.7222.93Price / Book6.894.938.475.47Net Income-$60.39M$495.21M$3.26B$994.60M7 Day Performance-0.90%-2.23%3.55%3.03%1 Month Performance-2.96%-3.76%5.96%1.98%1 Year Performance22.39%10.96%42.69%16.39% Senseonics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SENSSenseonics2.0517 of 5 stars$0.48+1.9%$1.55+221.4%+22.9%$315.46M$25.47M-3.7190News CoverageAnalyst RevisionTRNSTranscat3.2584 of 5 stars$74.80+0.3%$112.20+50.0%-28.3%$697.14M$278.42M47.951,245News CoveragePositive NewsEarnings ReportAnalyst RevisionEYPTEYEPOINT PHARMACEUTICALS1.9801 of 5 stars$10.06+3.6%$25.67+155.1%+28.6%$692.23M$43.27M-4.17120Earnings ReportALNTAllient1.8549 of 5 stars$39.67+4.3%$31.00-21.9%+120.4%$671.61M$529.97M67.242,525Earnings ReportDividend AnnouncementAEHRAehr Test Systems1.4659 of 5 stars$19.03+13.0%N/A+47.9%$569.38M$58.97M-146.3790Positive NewsGap UpLABStandard BioTools1.7377 of 5 stars$1.32+1.5%$2.50+89.4%-17.6%$501.36M$174.43M-3.77620News CoverageAnalyst DowngradeGap DownCTKBCytek Biosciences2.533 of 5 stars$3.84+5.5%$5.60+45.8%-22.9%$461.04M$197.05M-42.66500News CoverageQTRXQuanterix2.0606 of 5 stars$6.04+3.1%$13.50+123.5%-57.8%$301.70M$137.42M-4.65460News CoverageEarnings ReportAnalyst ForecastFEIMFrequency Electronics1.4783 of 5 stars$27.73+4.8%N/A+150.9%$269.81M$69.81M11.23200High Trading VolumeQSIQuantum-Si2.724 of 5 stars$1.44-1.4%$3.48+141.3%+39.7%$267.91M$3.44M-2.12150Gap UpMASS908 Devices3.0489 of 5 stars$6.52+1.6%$5.33-18.2%+52.2%$233.81M$63.99M-12.0760 Related Companies and Tools Related Companies TRNS Alternatives EYPT Alternatives ALNT Alternatives AEHR Alternatives LAB Alternatives CTKB Alternatives QTRX Alternatives FEIM Alternatives QSI Alternatives MASS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SENS) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senseonics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.